Select Presentations

Ryan PB, Wilson MR, Hansen RA. The role of data mining in hospital discharge data for active pharmacovigilance surveillance. Podium presentation at the 2007 Annual Meeting of the American Informatics Association, November 13, 2007, Chicago, IL.

Gartlehner G, Hansen RA, Thieda P, Gaynes BN, DeVeaugh-Geiss A, Krebs EE, Lohr KN. The comparative efficacy of second-generation antidepressants for the acute-phase treatment of major depressive disorder: a systematic review and meta-analysis. Poster presentation at the 10th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, October 21, 2007, Dublin, Ireland.

Dusetzina S, Farley JF, Hansen RA. Relationship between state Medicaid copayment policies and prescription drug utilization.  Podium presentation at the Southern Pharmacy Administration Conference, June 15-17, 2007, Little Rock, AK.

Leinwand B, Woodard B, Hansen RA.  Geographical information system mapping is a powerful tool for identifying health care need and in pharmacy business planning.  Podium presentation at the Southern Pharmacy Administration Conference, June 15-17, 2007, Little Rock, AK.

Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Agreement among treatment adherence measures in patients with cardiovascular disease. Poster presentation at the 2007 Annual Meeting of the American Pharmacists Association, March 16-19, 2007, Atlanta, GA.

Gartlehner G,  Hansen RA, Nissman D, Lohr KN, Thieda P, Carey TS. Criteria for Distinguishing Effectiveness from Efficacy Trials in Systematic Reviews. Poster Board Presentation. The Cochrane Collaboration – North American Systematic Reviewers Conference. Baltimore, July 13-14, 2006.

Hansen RA, Gartlehner G, Kaufer D. Functional outcomes of drug treatment in Alzheimer’s disease: a systematic review and meta-analysis. Podium presentation at the 2006 Annual Meeting of the American Pharmacists Association, March 17-21, 2006, San Francisco, CA.

Tiwari R, Hansen RA, Gartlehner G. Systematic review and meta-analysis of second-generation antidepressant treatment outcomes in social anxiety disorder. Poster presentation at the Annual Conference of the American Society for Health System Pharmacists, December 4-8, 2005, Las Vegas, NV.

McAllister J IV, McAllister J III, Duda D, Hansen RA, Eckel S. Determining medication reconcilliation adverse drug events for discharged patients at an academic medical center. Poster presentation at the Annual Conference of the American Society for Health System Pharmacists, December 4-8, 2005, Las Vegas, NV.

Duda D, McAllister J IV, McAllister J III, Hansen RA. Medication reconciliation during patient transfer in and out of intensive care units in an academic medical center; collection of baseline medication variance data. Poster presentation at the Annual Conference of the American Society for Health System Pharmacists, December 4-8, 2005, Las Vegas, NV.

Gartlehner G, Hansen RA, Carey TS, et al. Evidence-based medicine as a decision-making tool for health policy makers: a systematic review of second-generation antidepressants for major depressive disorder. Poster Presentation at the Annual Conference of the European Public Health Association, November 10-12, 2005, Graz, Austria

Gartlehner G, Hansen RA, Lohrs KN, et al. A systematic review to guide consumers’ decisions: second-generation antidepressant for the treatment of major depressive disorder. Poster presentation at the 6th International Conference on the Scientific Basis of Health Services. September 18-20, 2005, Montreal, Canada.

Hansen RA, Greene SB, Williams CE, Crook KD, Akers R, Carey TS. Beers drugs and medication error reports in North Carolina nursing homes.  Poster presentation at the 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 21-24, 2005, Nashville, TN

Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC. Discontinuation rates for SSRIs and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.  Poster presentation at the 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 21-24, 2005, Nashville, TN

Greene SB, Williams CE, Hansen RA, Crook KD, Akers R, Carey TS. Medication errors in nursing homes: a states experience implementing a reporting system.  Poster presentation at the 2005 Academy Health meeting, June 26-28, 2005, Boston, MA.

Fu AZ, Hansen RA, Christensen DB. Effect of second-generation antidepressant discontinuation on depressive relapse in adult patients with bipolar disorder.  Podium presentation at the 2005 Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research, May 15-18, 2005, Crystal City, VA.

Hansen RA, Shaheen NJ, Schommer JC. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Poster presentation for the 2005 Digestive Diseases Week meeting, May 15-19, 2005, Chicago, IL

Trygstad TK, Hansen RA, Wegner SE. An epidemiological approach to evaluating product switching behavior following the over-the-counter conversion of loratadine in a Medicaid population.  Podium presentation for the 2005 Annual Meeting of the American Pharmacists Association, April 1-5, 2005, Orlando, FL

Hansen RA, Gartlehner G. Drug class review on second-generation antidepressants.  Workshop presentation at the Drug Effectiveness Review Project biannual governance meeting, October 27-29, 2004, Portland, OR.

Hansen RA, Trygstad TK, and Wegner S.  The effect of Medicaid coverage decisions on second-generation antihistamine utilization and spending following over-the-counter availability of loratadine.  Podium (and poster) presentation for the 2004 Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, May 16-19, 2004, Crystal City, VA.

Hansen RA, Schommer JC, and Cline RR. The effect of direct-to-consumer advertising on prescription drug use among the insured.  Podium presentation for the 2004 annual meeting of the American Pharmacists Association, March 26-30, 2004, Seattle, WA.

Hansen RA and Schommer JC.  Methodological issues in evaluating the effect of localized direct-to-consumer prescription drug advertisements: the case of the retrospective cohort study.  Poster presentation for the 2003 annual meeting and exposition of the American Association of Pharmaceutical Scientists, October 25-29, 2003, Salt Lake City, Utah

Hansen RA and Schommer JC.  Theories of advertising applied to direct-to-consumer advertising of prescription drugs.  Poster presentation for the 2003 annual meeting and exposition of the American Association of Pharmaceutical Scientists, October 25-29, 2003, Salt Lake City, Utah

Schommer JC, Singh R, and Hansen RA.  Does advertising result in medicalizing normal human experience or trivializing prescription drug use?  Poster presentation for the 2003 annual meeting and Exposition of the American Association of Pharmaceutical Scientists, October 25-29, 2003, Salt Lake City, Utah

Hansen RA, Schommer JC, Mott DA, and Cline RR.  Exploring prescription drug coverage and drug use for older Americans – 2001,” Poster presentation for the 2003 annual meeting of the American Pharmaceutical Association, March 28 – April 2, 2003, New Orleans, LA

Schommer C, Singh R, and Hansen RA.  Patients’ information seeking and requests about prescription drugs advertised in 2001-2002,” Poster presentation for the 2003 annual meeting of the American Pharmaceutical Association, March 28 – April 2, 2003, New Orleans, LA